CoLucid Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (17)

View All

Latest Posts

About This Stock More About This Stock
Trump Twitter Hangover Keeps Biotech Stocks Down
Article By: Rod Raynovich
Thursday, January 19, 2017 1:30 AM EDT
Biotech stocks were getting traction until Day 3 of the J.P.Morgan Healthcare Conference when Trump tweeted out his attack on drug prices suggesting Medicare negotiate for a better deal on drug prices.
In this article: LLY, IBB, SGEN, BIIB, VRTX, XBI, RDUS, CLCD
Read
4 Biotech Stocks That More Than Doubled In 2016
Article By: Arpita Dutt
Thursday, December 22, 2016 11:47 AM EDT
2016 has not been a great year for biotech stocks, which were under intense pressure with issues like increasing political and media focus on high price tags for drugs, and the changing competitive scenario weighing on the sector.
In this article: CLCD, EXEL, TSRO, AKAO
Read
Why After A Massive Run, CoLucid Shares Still Look Attractive
Article By: Jason Napodano
Monday, October 31, 2016 9:02 AM EDT
CoLucid Pharmaceuticals shares are up ~290% YTD, and I think that's just the beginning.
In this article: CLCD Also: AGN, LLY, MRK, AMGN, TEVA, ALDR, XBI
Read
CoLucid Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Friday, September 9, 2016 5:45 PM EDT
CoLucid Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 3,250,000 shares of its common stock at a public offering price of $20.00 per share, for aggregate gross proceeds of $65.0 million.
In this article: CLCD
Read
All Posts

Latest Tweets for $CLCD

No tweets yet!

PARTNER HEADLINES